Clinical Trial

Biomarkers for Peripheral Circadian Clocks in Humans

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this project is to improve our understanding of peripheral circadian rhythms in humans. Circadian clocks are present in most tissues of the body with importance for optimal physiological function, health, and behavior. This project will utilize simulated jetlag protocols to systematically test novel hypotheses about the regulation of peripheral circadian rhythms in humans. Specifically, we will examine how changes in the time of when we are exposed to light and the timing of when we eat impacts proteins in the blood and saliva that represent rhythms from clocks in the brain (e.g., rhythms of the hormones melatonin and cortisol coordinated by the brain) and rhythms from clocks in body tissues (e.g., proteins made by immune and bone cells, and cells in the stomach and liver). We also aim to discover new blood-based biomarkers of peripheral rhythms in humans. We anticipate our findings will be the first step in developing novel circadian based treatments for aligning peripheral clocks under conditions such as jetlag, and for developing novel circadian biomarkers that will advance our scientific understanding of circadian rhythms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-29.
Trial Details
NCT Number NCT06296823
Lead Sponsor University of Colorado, Boulder
Collaborators: University of Colorado, Denver
Conditions Circadian Rhythms
Enrollment 14 participants
Start Date 2023-09-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-17